Circadian Rhythm Sleep Disorders Market

Circadian rhythm sleep disorders are caused by desynchronization between internal sleep-wake rhythms and the light-darkness cycle. Patients typically have insomnia, excessive daytime sleepiness, or both, which typically resolve as the body clock realigns itself.

Circadian Rhythm Sleep Disorders Market contains market size and forecasts of Circadian Rhythm Sleep Disorders in Global, including the following market information:

• Global Circadian Rhythm Sleep Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Circadian Rhythm Sleep Disorders market was valued at 868.4 million in 2021 and is projected to reach US$ 1144.3 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Delayed Sleep Phase Disorder (DSP) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Circadian Rhythm Sleep Disorders include Arena Pharmaceuticals, Boehringer Ingelheim, Fabre-Kramer Pharmaceuticals, Jazz Pharmaceuticals, Merck & Co, Glaxo Smith Kline, Respirerx Pharmaceuticals and Neurocrine Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Circadian Rhythm Sleep Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Circadian Rhythm Sleep Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Circadian Rhythm Sleep Disorders Market Segment Percentages, by Type, 2021 (%)

• Delayed Sleep Phase Disorder (DSP)
• Jet Lag Disorder
• Irregular Sleep-Wake Rhythm
• Free-Running (nonentrained) Type
• Shift Work Disorder
• Advanced Sleep Phase Disorder (ASP)

Global Circadian Rhythm Sleep Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Circadian Rhythm Sleep Disorders Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Sleep Centers
• Home Care Settings

Global Circadian Rhythm Sleep Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Circadian Rhythm Sleep Disorders Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Circadian Rhythm Sleep Disorders revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Circadian Rhythm Sleep Disorders revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceuticals
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences